RecallDepth
Class II Ongoing

Metformin Hydrochloride Extended-Release Tablets USP, 750 mg, a) 100 ct. bottle (NDC 70010-492-01) and 500 ct. bottle (NDC 70010-492-05), Manufactured for: Granules Pharmaceutical Inc., Chantilly, VA, Manufactured by: Granules India Limited, Hyderabad - 500-081, India

This recall is currently active, issued July 22, 2020. It was issued by Granules Pharmaceuticals Inc..

Company
Granules Pharmaceuticals Inc.
Recall Initiated
July 3, 2020
Posted
July 22, 2020
Recall Number
D-1386-2020
Voluntary / Mandated
Voluntary: Firm initiated
Quantity
a) 476,073 bottles; b) 2,100 bottles
Firm Location
Chantilly, VA, United States
Official Source
View on FDA website ↗

Reason for Recall

CGMP Deviations: FDA analysis detected N-Nitrosodimethylamine (NDMA) impurity above the acceptable intake level

Distribution

US Nationwide

Lot / Code Info

a) 100 count 4920003A/May-21 4920004A/Jun-21 4920005A/Jun-21 4920009A/Nov-21 4920010A/May-22 4920011A/Jun-22 4920012A/Jun-22 4920013A/Jul-22 4920014A/Jul-22 4920015A/Aug-22 4920016A/Jan-23 b) 500 count 4920005B/Jun-21

More recalls by Granules Pharmaceuticals Inc.

View all recalls by this company →

Other recent Class II Drug recalls